Advertisement
Home »

Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness.

Jan 02, 2023

ABOUT THE CONTRIBUTORS

  • Holly Burrows

    Yale School of Public Health, Yale University, New Haven, CT, USA. Electronic address: holly.burrows@princeton.edu.

    Marina Antillón

    Yale School of Public Health, Yale University, New Haven, CT, USA; Swiss Tropical and Public Health Institute, Allschwil, Switzerland; University of Basel, Basel, Switzerland.

    Jillian S Gauld

    Institute for Disease Modeling, Bill & Melinda Gates Foundation, Seattle, WA, USA.

    Jong-Hoon Kim

    Public Health, Access, and Vaccine Epidemiology (PAVE) Unit, International Vaccine Institute, Seoul, Republic of Korea.

    Vittal Mogasale

    Policy and Economic Research Department, International Vaccine Institute, Seoul 08826, Republic of Korea.

    Theresa Ryckman

    Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

    Jason R Andrews

    Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA.

    Nathan C Lo

    Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.

    Virginia E Pitzer

    Yale School of Public Health, Yale University, New Haven, CT, USA. Electronic address: virginia.pitzer@yale.edu.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement